Best Agrolife (539660) Q3 24/25 earnings summary

Executive summary

• Q3 FY2025 performance was impacted by adverse weather in South India, leading to weak demand from key crops and reduced agrochemical sales.

• Shift towards B2C business with expanded branded product portfolio and dealer network increased short-term costs but is seen as essential for long-term growth.

• Strategic partnership formed with Shanghai E-Tong Chemical Co. for joint R&D and manufacturing, and new patents granted in India and Africa.

• Branded sales increased to 72% of total sales in 9M FY25, but price erosion and reduced demand offset volume growth.

• Board approved unaudited standalone and consolidated results for Q3 and nine months ended 31 Dec 2024; results reviewed by statutory auditors.

Financial highlights

• Q3 FY2025 consolidated revenue from operations was INR 315.18 crore, down from INR 315 crore in Q3 FY2024; standalone revenue was INR 194.14 crore.

• EBITDA (excluding other income) was negative INR 6 crore; consolidated net loss for the quarter was INR 24.16 crore.

• Gross margin improved to 32% from 23% year-over-year due to higher branded product sales.

• Cash flow from operations for nine months was INR 177 crore; Q3 cash flow was INR 32 crore.

• Foreign currency loss of INR 11.36 crore in Q3 FY25 due to INR weakness.

Outlook and guidance

• FY2025 revenue will not reach the previously guided INR 2,000+ crore due to lower technical sales and underperformance in key southern states.

• Focus on cost reduction, operational optimization, and margin improvement in upcoming quarters.

• Plans to launch new patented herbicide and fungicide products in FY25.

• Management has not identified the need for any adjustments in results due to ongoing tax investigation; no changes to business outlook disclosed.